Clinical Trials Browser

Phase 2/3 × OTHER × Neoplasms, Second Primary × Clear all

NCT03458221 2023-04-18

STAPOVER

Phase 2/3 Recruiting

Ovarian Neoplasms, Neoplasms, Second Primary